Cannell Thomas R has filed 4 insider transactions across 1 company since February 2023.
Most recent transaction: a sale of 208923 shares of Carisma Therapeutics Inc. ($CARM) on March 02, 2023.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2023 | Carisma Therapeutics Inc. | $CARM | Cannell Thomas R | President and CEO | S | Common Stock | 208923 | $0.59 | 344,150.0000 | 0 | 37.77% | 0.00% |
| March 2, 2023 | Carisma Therapeutics Inc. | $CARM | Cannell Thomas R | President and CEO | M | Common Stock | 606800 | $0.59 | 950,950.0000 | 0 | 176.32% | 0.00% |
| March 2, 2023 | Carisma Therapeutics Inc. | $CARM | Cannell Thomas R | President and CEO | S | Common Stock | 278564 | $0.59 | 672,386.0000 | 0 | 29.29% | 0.00% |
| Feb. 21, 2023 | Carisma Therapeutics Inc. | $CARM | Cannell Thomas R | President and CEO | S | Common Stock | 53727 | $0.59 | 553,073.0000 | 0 | 8.85% | 0.00% |